Menu

Filtros : "Financiamento FAPESP" "Clinical Epigenetics" Removido: "EE-ENC" Limpar

Filtros

Limitar por data

  • 1

1 - 2 (2 registros)

  • Artigo de periodico

    A systematic evaluation of normalization methods and probe replicability using infinium EPIC methylation data (2023)

    Welsh, H; Batalha, C. M. P. F; Li, W; Mpye, K. L; Souza-Pinto, Nadja Cristhina de ; Naslavsky, Michel ; Parra, E. J

    Fonte: Clinical Epigenetics. Unidades: IQ, IB

    Assunto: METILAÇÃO DE DNA

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      WELSH, H et al. A systematic evaluation of normalization methods and probe replicability using infinium EPIC methylation data. Clinical Epigenetics, v. 15, p. 1-12 art. 41, 2023Tradução . . Disponível em: https://doi.org/10.1186/s13148-023-01459-z. Acesso em: 08 out. 2025.

    • APA

      Welsh, H., Batalha, C. M. P. F., Li, W., Mpye, K. L., Souza-Pinto, N. C. de, Naslavsky, M., & Parra, E. J. (2023). A systematic evaluation of normalization methods and probe replicability using infinium EPIC methylation data. Clinical Epigenetics, 15, 1-12 art. 41. doi:10.1186/s13148-023-01459-z

    • NLM

      Welsh H, Batalha CMPF, Li W, Mpye KL, Souza-Pinto NC de, Naslavsky M, Parra EJ. A systematic evaluation of normalization methods and probe replicability using infinium EPIC methylation data [Internet]. Clinical Epigenetics. 2023 ; 15 1-12 art. 41.[citado 2025 out. 08 ] Available from: https://doi.org/10.1186/s13148-023-01459-z

    • Vancouver

      Welsh H, Batalha CMPF, Li W, Mpye KL, Souza-Pinto NC de, Naslavsky M, Parra EJ. A systematic evaluation of normalization methods and probe replicability using infinium EPIC methylation data [Internet]. Clinical Epigenetics. 2023 ; 15 1-12 art. 41.[citado 2025 out. 08 ] Available from: https://doi.org/10.1186/s13148-023-01459-z

  • Artigo de periodico

    Genome-wide promoter methylation profling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival (2022)

    Rius, Flávia Eichemberger ; Papaiz, Debora D'Angelo ; Azevedo, Hátylas ; Ayub, Ana Luísa P ; Pessoa, Diogo de Oliveira ; Oliveira, Tiago Franco de ; Loureiro, Ana Paula de Melo ; Andrade, Fernando; Fujita, André ; Reis, Eduardo Moraes ; Mason, Christopher E; Jasiulionis, Miriam Galvonas

    Fonte: Clinical Epigenetics. Unidades: IME, FCF, IQ

    Assuntos: GENOMAS, MELANOMA, BIOINFORMÁTICA

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      RIUS, Flávia Eichemberger et al. Genome-wide promoter methylation profling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival. Clinical Epigenetics, v. 14, n. artigo 68, p. 1-20, 2022Tradução . . Disponível em: https://doi.org/10.1186/s13148-022-01291-x. Acesso em: 08 out. 2025.

    • APA

      Rius, F. E., Papaiz, D. D. 'A., Azevedo, H., Ayub, A. L. P., Pessoa, D. de O., Oliveira, T. F. de, et al. (2022). Genome-wide promoter methylation profling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival. Clinical Epigenetics, 14( artigo 68), 1-20. doi:10.1186/s13148-022-01291-x

    • NLM

      Rius FE, Papaiz DD'A, Azevedo H, Ayub ALP, Pessoa D de O, Oliveira TF de, Loureiro AP de M, Andrade F, Fujita A, Reis EM, Mason CE, Jasiulionis MG. Genome-wide promoter methylation profling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival [Internet]. Clinical Epigenetics. 2022 ; 14( artigo 68): 1-20.[citado 2025 out. 08 ] Available from: https://doi.org/10.1186/s13148-022-01291-x

    • Vancouver

      Rius FE, Papaiz DD'A, Azevedo H, Ayub ALP, Pessoa D de O, Oliveira TF de, Loureiro AP de M, Andrade F, Fujita A, Reis EM, Mason CE, Jasiulionis MG. Genome-wide promoter methylation profling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival [Internet]. Clinical Epigenetics. 2022 ; 14( artigo 68): 1-20.[citado 2025 out. 08 ] Available from: https://doi.org/10.1186/s13148-022-01291-x
  • 1

1 - 2 (2 registros)

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2025